Xi'an Quanao Biotech Co., Ltd.
Fluoxetine Hydrochloride Powder,Fluoxetine Hydrochloride 99%,Cas No 56296-78-7
Unit Price: | 16~170 USD |
---|---|
Payment Type: | T/T,L/C,D/P,D/A,Paypal,Others |
Incoterm: | DDP,CIP,CPT,FCA,CIF,EXW,CFR,FOB,DDU,Express Delivery,DEQ,DAF,DES |
Min. Order: | 1 Kilogram |
Model No.: Fluoxetine Hydrochloride
Brand: quanao
MOQ: 1 Kg
Particle Size: 100% Pass 80 Mesh
Shelf Life: 2 Years
Appearance: White Powder
Specification: 98%
Product Name: Fluoxetine Hydrochloride
Test Method: HPLC
CAS: 56296-78-7
Ingredients: Fluoxetine Hydrochloride
Source: Fluoxetine Hydrochloride
Packaging: packed in: 1kg with double plastic container inside/Aluminum foil bag outside. 25kg with double plastic container inside/Fiber drum outside.
Productivity: 50T/Month
Transportation: Ocean,Land,Air,Express,Others
Place of Origin: China,xi'an
Supply Ability: 50T/Month
Certificate: organinc,halal,iso
HS Code: 391239000
Port: Shanghai,Ningbo,Tianjin
Payment Type: T/T,L/C,D/P,D/A,Paypal,Others
Incoterm: DDP,CIP,CPT,FCA,CIF,EXW,CFR,FOB,DDU,Express Delivery,DEQ,DAF,DES
Active Pharmaceutical Ingredients Fluoxetine was shown to be effective for depression in six-week-long double-blind controlled trials, where it also alleviated anxiety and Sleeping Help Material. Medicine Raw Material Fluoxetine was better than placebo for the prevention of depression recurrence when the patients, who originally responded to fluoxetine, were treated for a further 38 weeks. Efficacy of fluoxetine for geriatric, as well as pediatric, depression was also demonstrated in placebo-controlled trials. Research suggests that a significant part of the resistance to the SSRIs paroxetine (Paxil) and citalopram(Celexa) can be explained by the genetic variation of Pgp transporter. Paroxetine and citalopram, which are Pgp substrates, are actively transported from the brain by this protein. Fluoxetine is not a substrate of Pgp, and thus a switch from paroxetine or citalopram to fluoxetine may be beneficial to the nonresponders.
Fluoxetine Hydrochloride Powder 99%
Cas No 56296-78-7
[Product Name]: Fluoxetine Hydrochloride
[Apperance]: White Powder
[Specification]: 98%
[Test Method]: HPLC
[Storage]: Store in a cool, dry place and sealed container.
Fluoxetine hcl is frequently used to treat major depression, obsessive compulsive disorder, bulimia nervosa,panic disorder, body dysmorphic disorder, premenstrual dysphoric disorder, and trichotillomania. Caution should be taken when using any SSRI for bipolar disorder as this can increase the likelihood of mania; however, fluoxetine can be used with an antipsychotic (such as quetiapine) for bipolar. It has also been used for cataplexy, obesity, and alcohol dependence,as well as binge eating disorder.
Fluoxetine hcl was shown to be effective for depression in six-week-long double-blind controlled trials, where it also alleviated anxiety and improved sleep. Fluoxetine was better than placebo for the prevention of depression recurrence when the patients, who originally responded to fluoxetine, were treated for a further 38 weeks. Efficacy of fluoxetine for geriatric, as well as pediatric, depression was also demonstrated in placebo-controlled trials.
Medical uses:
Fluoxetine is frequently used to treat major depressive disorder, obsessive-compulsive disorder (OCD), post-traumatic stress disorder (PTSD), bulimia nervosa, panic disorder, premenstrual dysphoric disorder, and trichotillomania.It has also been used for cataplexy, obesity, and alcohol dependence,as well as binge eating disorder.It has also been tried as a treatment for autism spectrum disorders with moderate success in adults.
Obsessive-compulsive disorder:
The efficacy of fluoxetine in the treatment of obsessive-compulsive disorder (OCD) was demonstrated in two randomized multicenter phase III clinical trials. The pooled results of these trials demonstrated that 47% of completers treated with the highest dose were "much improved" or "very much improved" after 13 weeks of treatment, compared to 11% in the placebo arm of the trial.The American Academy of Child and Adolescent Psychiatry state that SSRIs, including fluoxetine, should be used as first-line therapy in children, along with cognitive behavioral therapy (CBT), for the treatment of moderate to severe OCD.
Panic disorder:
The efficacy of fluoxetine in the treatment of panic disorder was demonstrated in two 12-week randomized multicenter phase III clinical trials that enrolled patients diagnosed with panic disorder, with or without agoraphobia. In the first trial, 42% of subjects in the fluoxetine-treated arm were free of panic attacks at the end of the study, vs. 28% in the placebo arm. In the second trial, 62% of fluoxetine treated patients were free of panic attacks at the end of the study, vs. 44% in the placebo arm.
Our Hot Sales products are: Phenibut HCL, St.John’s Wort Extract, Coluracetam Powder, Rhodiola Rosea Extract and so on.
Product Categories : Active Pharmaceutical Ingredients > Anti-Depression Ingredients